| abstract |
The present invention relates to N 5- (pyrimidin-4-yl) -1H-indazol-3,5-diamine derivatives represented by the following general formula (1), isomers thereof or pharmaceutically acceptable salts thereof: [Formula 1] (In Formula 1, R1 is hydrogen, substituted or unsubstituted acetyl, or substituted or unsubstituted benzoyl; R2 is halogen, hydroxy, substituted or unsubstituted amine, lower alkoxy or substituted lower alkoxy.) |